References
- Weinstein IB. Cancer. Addiction to oncogenes-the Achilles heel of cancer. Science 297, 63–634 (2002).
- Weinstein IB, Joe A. Oncogene addiction. Cancer Res. 68, 3077–3080 (2008).
- Jørgensen JT. Companion diagnostics in oncology ∼ current status and future aspects. Oncology 85, 59–68 (2013).
- Nowak F, Soria JC, Calvo F. Tumour molecular profiling for deciding therapy-the French initiative. Nat. Rev. Clin. Oncol. 9, 479–486 (2012).
- Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11, 426–437 (2011).
- Murtaza M, Dawson SJ, Tsui DW et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108–112 (2013).
Websites
- European Symposium of Biopathology. http://en.symposium.eu.com/European-Symposium-of-Biopathology-2013-Scientific-program_a22.html ( Accessed 28 June 2013)
- Chustecka Z. Slew of Targeted Cancer Drugs on the Way. Medscape Medical News, March 1. (2012). www.medscape.com/viewarticle/759523 ( Accessed 29 June 2013)
- FDA. In Vitro Companion Diagnostic Devices. Draft Guidance. (2011). www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM262327.pdf ( Accessed 4 August 2013)